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Abstract
Background: Angola's malaria case-management policy recommends treatment with artemether-
lumefantrine (AL). In 2006, AL implementation began in Huambo Province, which involved training
health workers (HWs), supervision, delivering AL to health facilities, and improving malaria testing
with microscopy and rapid diagnostic tests (RDTs). Implementation was complicated by a policy
that was sometimes ambiguous.
Methods: Fourteen months after implementation began, a cross-sectional survey was conducted
in 33 outpatient facilities in Huambo Province to assess their readiness to manage malaria and the
quality of malaria case-management for patients of all ages. Consultations were observed, patients
were interviewed and re-examined, and HWs were interviewed.
Results:  Ninety-three HWs and 177 consultations were evaluated, although many sampled
consultations were missed. All facilities had AL in-stock and at least one HW trained to use AL and
RDTs. However, anti-malarial stock-outs in the previous three months were common, clinical
supervision was infrequent, and HWs had important knowledge gaps. Except for fever history, clinical
assessments were often incomplete. Although testing was recommended for all patients with
suspected malaria, only 30.7% of such patients were tested. Correct testing was significantly
associated with caseloads < 25 patients/day (odds ratio: 18.4; p < 0.0001) and elevated patient
temperature (odds ratio: 2.5 per 1°C increase; p = 0.007). Testing was more common among AL-
trained HWs, but the association was borderline significant (p = 0.072). When the malaria test was
negative, HWs often diagnosed patients with malaria (57.8%) and prescribed anti-malarials (60.0%).
Sixty-six percent of malaria-related diagnoses were correct, 20.1% were minor errors, and 13.9%
were major (potentially life-threatening) errors. Only 49.0% of malaria treatments were correct, 5.4%
were minor errors, and 45.6% were major errors. HWs almost always dosed AL correctly and gave
accurate dosing instructions to patients; however, other aspects of counseling needed improvement.
Conclusion:  By late-2007, substantial progress had been made to implement the malaria case-
management policy in a setting with weak infrastructure. However, policy ambiguities, under-use of
malaria testing, and distrust of negative test results led to many incorrect malaria diagnoses and
treatments. In 2009, Angola published a policy that clarified many issues. As problems identified in this
survey are not unique to Angola, better strategies for improving HW performance are urgently needed.
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Background
Malaria is a major cause of morbidity and mortality in
sub-Saharan Africa, and prompt treatment with an effec-
tive anti-malarial is a pillar of malaria control. For dec-
ades, as most health facilities in Africa did not perform
diagnostic testing, uncomplicated malaria was typically
managed with a syndromic approach in which all patients
with febrile illness were treated with chloroquine. Since
2000, in the face of increasing resistance to chloroquine
and other commonly-used anti-malarials, 45 African
countries changed their case-management policies to rec-
ommend artemisinin-based combination therapy (ACT)
as the first-line treatment for uncomplicated malaria [1,2].
To reduce unnecessary ACT use, malaria diagnostic testing
with microscopy or rapid diagnostic tests (RDTs) is often
recommended.
Despite substantial investments by donors, African gov-
ernments, and other partners to support these new diag-
nostic and treatment policies, remarkably little is known
about how well the policies have been implemented. Pub-
lished studies of health worker adherence to ACT policies
have only been done in three low-income countries
(Kenya, Uganda, and Zambia) [3-9]; and use of testing
was evaluated in only two (Kenya and Zambia) [5-7].
Results from these studies are concerning. The proportion
of patients needing ACT who received it was often low
(range: 26-64%), as was the proportion of patients need-
ing testing who were tested (range: 27-56%). Notably, one
study from an upper-middle income country (South
Africa, where malaria transmission is very limited and
health facilities in malaria endemic areas are staffed with
personnel from the malaria control programme to per-
form testing) [1] found that all patients with a febrile ill-
ness were tested and all test-positive patients were treated
with anti-malarials.
Although malaria transmission, malaria control pro-
grams, and levels of socioeconomic development vary
widely across Africa, evaluations of real-world implemen-
tation of ACT in specific settings can reveal programmatic
strengths, weaknesses, and lessons that might benefit
other parts of the continent. This report presents such an
evaluation in Huambo Province, Angola, where the scale-
up of ACT and diagnostic testing was supported by the
U.S. President's Malaria Initiative [10]. First, a narrative is
provided that describes how the ACT policy was imple-
mented. Second, a survey is presented that assessed health
facility and health worker readiness to manage malaria
cases and the quality of malaria case management.
ACT implementation
Angola's ACT policy was adopted in 2004, although as
early as 2003 ACT had been supplied and short trainings
conducted in some health facilities in Huambo. In Febru-
ary 2006, the National Malaria Control Programme
(NMCP) began disseminating the policy with a five-day
training course for 20 trainers from across Angola, includ-
ing one from Huambo. While many trainings were held
over the next several years, it is notable that the ACT policy
document was only finalized in 2008 and published in
2009 [11]. Furthermore, in 2007 (when the survey
described in this report was being planned), the draft pol-
icy document was somewhat ambiguous on malaria diag-
nosis [12]. The document defined a malaria case as
anyone with fever and a positive test for Plasmodium. It
then had a "clinical case" section that listed signs and
symptoms of uncomplicated malaria without further
explanation. The document stated that malaria cannot be
ruled out in patients with a negative test and no other
cause of fever and that the World Health Organization
(WHO) recommends that malaria can be diagnosed
among children < 5 years old (under-5s) based on clinical
findings without laboratory testing. While these state-
ments provided general guidance on diagnosing malaria,
they left some questions. For example: 1) should under-5s
with fever be tested?; 2) how should non-fever signs and
symptoms be used to decide which patients should be
tested?; and 3) in patients with fever and a negative test,
which non-malaria causes of fever should be ruled out
before treating with an anti-malarial? (Note that the
recently published policy clarifies many of these issues--
see details below [11].)
In Huambo Province, the recommended ACT was arte-
mether-lumefantrine (AL). In 2007, in response to the
ambiguous policy, local malaria control staff developed
training materials that were based on the draft NMCP pol-
icy document, as well as WHO guidelines when the
NMCP policy was unclear. However, local staff did not
want to be seen as making their own policy. Therefore,
although the training materials provided some additional
precision on what health workers should do during con-
sultations, they were still not a comprehensive case-man-
agement guideline. From August-September 2006, the
training materials were used in 3-day courses for health
workers from 16 health facilities. From January-Novem-
ber 2007, 570 staff throughout the province were trained.
Courses typically lasted three days, involved clinicians,
pharmacists and laboratory technicians, and included
instruction on RDT use. Participants were expected to
share the information with others in their facilities (i.e.,
informal, cascade training), although there was a multi-
year plan to train additional health workers with the for-
mal three-day course. A multi-year plan was needed
because the public sector employs unusually large num-
bers of health workers (after Angola's civil war, many
nurses from the opposition faction were integrated into
the health system). Scale-up activities were conducted
with substantial external assistance, including staff fromMalaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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the NMCP, WHO, The MENTOR Initiative (a non-govern-
mental organization [13]), the U.S. Agency for Interna-
tional Development, and the U.S. Centers for Disease
Control and Prevention.
In September 2007 (a time when the availability of
malaria testing was still quite limited in Angola), the
NMCP Director modified the ACT policy to be in line with
WHO guidelines [14]: under-5s with suspected malaria in
areas with moderate or high transmission did not need
testing and could be presumptively treated for malaria.
The change was announced during a meeting, but not
incorporated into a published policy until 2009 [10].
Interestingly, one year after the September 2007
announcement, partners sometimes still had different
understandings of what presumptive treatment meant
(treat all under-5s with suspected malaria versus only treat
if no other cause of fever was found). The recently pub-
lished policy specifies that under-5s with a febrile illness
from areas with moderate or high malaria transmission
should be treated for malaria without testing [11]. Other
issues clarified by the published policy include the defini-
tion of a confirmed malaria case, how patients should be
managed if malaria testing is not available, and the possi-
bility that patients with cerebral malaria can have a nega-
tive test.
AL and RDTs were usually first supplied with the trainings.
Subsequently, the pharmaceutical management plan
called for monthly deliveries to health facilities. In prac-
tice, the time period varied. For several months before the
survey described in this report, commodities were not
supplied because of transportation difficulties from the
central warehouse in Luanda, Angola's capital. However,
commodities were delivered shortly before the survey.
Regarding other ACT implementation activities before the
survey, AL-related supervision and microscopy training
were just beginning. Regarding user fees, the policy calls
for free ACT and RDT testing at public facilities.
Methods
Study setting
Huambo Province, in the highlands of central Angola, has
meso-endemic, stable malaria transmission [15]. Trans-
mission peaks from November-April, with Plasmodium fal-
ciparum causing > 90% of infections. The population (2.3
million) is impoverished, and agriculture is a primary
source of economic activity [16]. About half (45%) live in
rural areas; and there is one urban center, the city of Hua-
mbo. During Angola's long civil war (1975-2002), Hua-
mbo was particularly hard hit. Much of the health
infrastructure was left severely damaged or destroyed, and
many land mines remain.
Study design and inclusion criteria
We conducted a cross-sectional cluster survey from Octo-
ber-November, 2007. A cluster was defined as all patient
consultations performed in an eligible health facility dur-
ing regular working hours (Monday-Friday, 8 am-3 pm)
during the survey period. Facilities were eligible if they
were a public or private facility in Huambo Province that
provided outpatient care and where the ACT policy had
been implemented (i.e., at least one health worker trained
on the policy and ACT delivered anytime in the past).
Fifty-seven eligible facilities were identified (eight hospi-
tals, 48 health centers, and one health post); all were gov-
ernment-run. Health workers were eligible if they
performed outpatient consultations with sick patients at
an eligible facility. Inclusion criteria for outpatient consul-
tations were any initial consultation for patients seeking
care for any illness at eligible facilities during regular
working hours. Initial consultation meant the patient's
first visit to the facility for the current illness.
Sample size and sampling
To minimize costs, a sample size of 30 health facilities was
chosen, which is the smallest number of clusters that
many experts advise for cluster surveys [17]. Assuming
10% of facilities would be permanently closed or inacces-
sible, the total sample size was 33 facilities. The list was
ordered by facility type (hospitals, health centers, and
health posts) and municipality (i.e., district), and 33 facil-
ities were selected with systematic sampling. Systematic
sampling was used to choose dates for each facility visit.
Survey teams attempted to include all initial consultations
using the "follow-the-patient" approach (see below).
However, in high-volume clinics, not all consultations
could be included. Surveyors reviewed patient registers
and averaged patients in the preceding 5 weekdays to esti-
mate daily caseload. Estimated caseload determined the
sampling fraction of patients: if < 21 patients were
expected, the sampling fraction was 100% (include all ini-
tial consultations); if 22-42 patients were expected, the
sampling fraction was 50% (every other initial consulta-
tion), etc. If not all consultations could be included,
patients were selected with systematic sampling (e.g.,
select every third patient, with the first chosen randomly).
Data collection
Two teams collected data, each consisting of three survey-
ors (all medical professionals), a laboratory technician,
and a driver. Survey organizers closely supervised data col-
lection. For eight days, surveyors practiced survey proce-
dures in a classroom setting and in health facilities not in
the sample. Concordance testing assessed observation
skills (with role-playing and videos of consultations) and
re-examination skills (with hospitalized patients), and
training continued until concordance (i.e., percent agree-Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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ment between surveyors and a gold standard determined
by survey organizers) was at least 90%; concordance was
typically about 96%.
Data were collected with standardized forms written in
Portuguese. Questions for patients were translated into
Umbundu, the local language and back-translated to ver-
ify accuracy. Interviews were conducted in the language
that subjects were most comfortable speaking.
Dates of survey visits were not announced in advance to
health facility staff. During visits, surveyors arrived before
8 am. Teams met with facility directors and health workers
performing consultations to introduce themselves,
describe the visit's purpose, and request verbal consent
from health workers.
As ill patients arrived at facilities, drivers identified
patients coming for an initial consultation and gave these
patients a card with a sequential identification number.
The cards were used to sample patients and confirm the
total number of initial consultations that day. Surveyors
met selected patients and requested verbal consent. Sur-
veyors silently observed consultations with a checklist to
record health worker practices. After the consultation, sur-
veyors asked health workers for the patient's diagnoses
and prescribed treatments. Surveyors then followed
patients through all other parts of the facility visit (e.g.,
laboratory, pharmacy) and silently recorded malaria-
related treatment instructions and counseling messages.
When patients were ready to leave the facility, surveyors
conducted an interview and focused re-examination in a
room out of view of the health facility staff to avoid influ-
encing routine practices. Dispensed medications were
recorded. If surveyors identified a patient who had not
been adequately treated for malaria or any other serious
illness, they provided treatment free of charge.
Non-pregnant patients ≥ 5 years old with suspected
malaria (defined below) were tested. Survey team labora-
tory technicians drew several drops of blood by finger
stick with a single-use sterile lancet to make a blood smear
and perform a RDT (Paracheck®, Orchid Diagnostics,
Mumbai, India). Blood smears were air dried in the field;
after the survey, they were stained with Giemsa and read
by an expert microscopist. The RDT was read in the field
after 15-25 minutes to ensure that parasitemic patients
were treated with an anti-malarial. The "old" (pre-Septem-
ber 2007) NMCP guidelines recommended testing for all
patients with suspected malaria, however the survey did
not test under-5s and pregnant women with suspected
malaria. The reasons were to minimize unnecessary
patient discomfort and the time patients spent with sur-
veyors. Due to a misunderstanding, it was thought the
policy stated that these two patient groups should be
treated with an anti-malarial regardless of the test result.
Therefore, as testing did not seem to affect the treatment,
these patients were not tested.
At the end of the visit, surveyors interviewed health work-
ers to obtain information on training, supervision, and
knowledge of malaria case management. Surveyors also
assessed the facility's equipment and drug stocks.
Definitions
Defining the standard for assessing the quality of malaria
testing, diagnosis, and treatment was challenging because:
1) policy and training materials sometimes lacked preci-
sion; 2) the survey protocol did not include testing for all
patients who should have been tested; and 3) the NMCP
policy changed just before the survey. Therefore, using
NMCP guidelines, an analysis algorithm was developed
with enough precision to analyze case-management qual-
ity in our sample of consultations (Figure 1). The algo-
rithm was based on the "old" pre-September 2007 policy
(test all patients with suspected malaria) as implemented
in Huambo Province because the "new" policy
(announced in September 2007, which recommended
presumptive treatment for under-5s) was just starting in
Huambo--only three health workers had been trained in
the new policy, and they only saw four patients in the
analysis. The algorithm incorporated case-management
principles actually conveyed to health workers during
training and provided disease classifications for the some-
what ambiguous instances in which patients that should
have been tested were not and vice-versa.
The analysis algorithm was used to make a "gold stand-
ard" determination of the patient's diagnosis and treat-
ment. Case-management quality was assessed by
comparing the observed health worker's diagnosis and
treatment with the gold standard. The analysis algorithm
did not use survey laboratory results; instead, it used
information that should have been available to health
workers (e.g., results of microscopy and RDTs ordered by
health workers). This approach is best for evaluating
adherence to a guideline, as it prevents classifying health
worker practices as erroneous if laboratory results from
the health facility did not match survey laboratory results.
Survey laboratory results were used in separate analyses.
The analysis algorithm used clinical signs and symptoms
from patient interviews and re-examinations performed
by surveyors.
As per the Huambo training materials, suspected malaria
was defined as either fever (by history or measured axil-
lary temperature > 37.5°C) or at least three of the follow-
ing: headache, joint pain, chills, sweating, anaemia, cough
(for children only), anorexia, fatigue, vomiting, or diar-
rhoea. Uncomplicated malaria was defined as malariaMalaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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(determined by the analysis algorithm) without signs of
severe illness (Figure 2), and complicated malaria was
defined as malaria with at least one sign of severe illness.
Definitions of non-malaria causes of fever used by the
algorithm are shown in Figure 2.
Definitions of treatment quality were based on surveyor-
measured patient weights and the NMCP's anti-malarial
dosing guidelines [12] (Figure 3). Malaria treatment qual-
ity was categorized as: 1) recommended (health worker's
prescribed treatment exactly matched the analysis algo-
rithm, including drug type, dosage, and treatment dura-
tion), 2) adequate (treatments were not recommended,
but still considered life-saving), or 3) inadequate (neither
recommended nor adequate). These three categories cor-
respond to correct treatment, minor errors, and major
errors, respectively [18].
Analysis
Data were double-entered with SPSS Data Entry version
1.0 (SPSS Inc., Chicago, Illinois) and validated against
paper questionnaires. Analyses were conducted with SAS
version 9.1 (SAS Institute, Inc., Cary, North Carolina).
Weights (for patient-level indicators only) were the prod-
uct of two components: (1/patient selection probability)
× a non-response adjustment (number of eligible patients
selected for enrollment [i.e., patients enrolled and
included in the analysis + selected patients missed by sur-
veyors + refusals + withdrawals + patients lost to follow-
up]/patients included in the analysis).
Descriptive analyses of patient and health worker-level
indicators were performed with the SURVEYFREQ proce-
dure, which uses the Taylor expansion method to account
for cluster sampling and unequal analysis weights. Health
Algorithm used to analyse the quality of malaria diagnosis and treatment, as it was applied in outpatient health facilities, Hua- mbo Province, Angola Figure 1
Algorithm used to analyse the quality of malaria diagnosis and treatment, as it was applied in outpatient 
health facilities, Huambo Province, Angola. a Defined as either fever (history of fever or axillary temperature > 37.5°C), 
or at least 3 of the following: headache, joint pain, chills, sweating, anaemia (palmor pallor), cough (applies to children only), 
anorexia, fatigue, vomiting, or diarrhoea. b Error (health worker's decision did not follow policy documents and training mate-
rials). c Result not available on the day of the consultation, patient asked to return the next day (this only occurred for 2 
patients). d This part of the algorithm was not explicitly included in policy documents or training materials; however, the deci-
sion could be logically inferred from policy documents or training materials. e Defined as cerebral dysfunction, cerebral malaria, 
disseminated intravascular coagulopathy, haemoglobinuria, hepatic dysfunction, hyperthermia, pulmonary oedema, renal insuffi-
ciency, severe anaemia, or shock. For details, see Figure 2. f Do not treat for malaria now; wait until result is ready and treat 
only if test is positive. g Defined as dysentery, hepatitis, influenza-like illness, measles, otitis, pneumonia, or urinary tract infec-
tion. For details, see Figure 2.
Does 
patient 
have 
suspected 
malariaa ?
Test patients 
of all ages
Does 
patient 
have other 
causeg of 
fever?
No
Do not treat for malaria; 
treat other illnesses
Yes
No
Do not test
Was patient 
tested by the 
observed health 
worker despite 
recommendation 
not to test?
Treat for malariad
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patient 
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No
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Test 
result?
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Do not treat 
for malariad
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Not availablec
Nob
Treat for malaria
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worker indicators were not weighted, as selection proba-
bilities were equal. Patient-level indicators were weighted,
unless otherwise noted. As the sample size of health facil-
ities (n = 33) was a relatively large proportion of all facil-
ities in the sampling frame (N = 57), confidence intervals
(CIs) for health facility-level indicators were adjusted with
the finite population correction factor--i.e., for a propor-
tion, p, the standard error = {square-root [p(1 - p)/n]} ×
{square-root [(N - n)/(N - 1)]}. If p = 0% or 100% (and
thus the estimated standard error would be zero), CIs
were estimated using the exact binomial method.
Logistic regression modeling was performed using the
SURVEYLOGISTIC procedure, which also uses the Taylor
expansion method to address clustering and weighting.
All models were weighted. Variables with a univariate p-
value < 0.15 were included in a multivariate model (the
full model). Reduced models were tested by removing var-
iables with a multivariate p-value > 0.10. Variables with a
multivariate p-value > 0.10 were not removed if odds
ratios of other variables changed by > 20%. To assess con-
founding by excluded variables (univariate p-value ≥
0.15), we added them to the reduced model one at a time
and retained them if odds ratios of other variables
changed by > 20%. Hypothesis testing and CI estimation
were done with an alpha of 0.05.
Results
Enrollment
Survey teams visited all 33 sampled health facilities as
scheduled. In these facilities, 100 health workers per-
formed outpatient consultations; 93 (93.0%) were inter-
viewed, and seven left before interviews could be
administered. No health worker refused to participate. Of
Definitions used in the survey analysis Figure 2
Definitions used in the survey analysis.
Signs of severe illness in the guidelines and how they were operationalized in the survey
1. “Cerebral dysfunction and cerebral malaria” in the guidelines was defined as: history of convulsions,      
.
2. “Disseminated intravascular coagulopathy” was defined as: spontaneous bleeding or bruising.
3. “Hemoglobinuria” was defined as: dark urine.
4. “Hepatic dysfunction” was defined as: jaundice.
5. “Hyperthermia” was defined as: temperature >41º C.
6. “Pulmonary edema” was defined as: respiratory distress.
7. “Renal insufficiency” was defined as: little or no urine.
8. “Severe anemia” was defined as: severe palmar pallor.
9. “Shock” was defined as: cyanosis, nail bed capillary refill >2 seconds, pulse that is weak and                      
.
Other causes of febrile illness and how they were operationalized in the survey
1. “Dysentery” in the guidelines was defined as: diarrhea and bloody stools.
2. “Hepatitis” was defined as: jaundice.
3. “Influenza-like illness” was defined as: nasal or sinus congestion.
4. “Measles” was defined as: measles rash or Koplic spots.
5. “Otitis” was defined as: ear pain.
6. “Pneumonia” was defined as: cough and either fast breathing or respiratory distress. Fast breathing            
.                                                               
.
7. “Urinary tract infection” was defined as: difficult or painful urination.
Note. The following signs of severe illness in the national policy were excluded in the survey analysis           
because testing could not be performed in the field (most health facilities also lacked the tests):              
hyperparasitemia (>100,000 parasites/mm3), hypoglycemia, hyponatremia, and metabolic acidosis. 
observed convulsions, lethargy, or unconsciousness.
>110 beats/minute, or systolic blood pressure <80 mm Hg (for adults only).
was defined as respiratory rates of >50 breaths/minute for ages <12 months, >40 breaths/minute for
ages 12–59 months, >30 breaths/minute for ages 5–13 years, and >20 breaths/minute for ages >13 years.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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the 93 workers interviewed, 64 treated at least one
included patient; and of the seven workers missed, six
treated at least one included patient. Thus, patient-level
indicators of case-management quality reflected the prac-
tices of 70 health workers (64 interviewed, six missed).
Altogether, 778 patients came for initial consultations;
389 of whom were selected for inclusion. Of these 389
patients, 177 were included, 170 were missed (i.e., no sur-
veyor was available to begin the "follow the patient" pro-
cedure), 38 refused, three withdrew after enrollment, and
one patient left the facility before completing all survey
steps. Although many selected patients were not surveyed
(i.e., 170 missed + 38 refusals + three withdrawals + one
lost, or 212 patients), most (170/212, or 80.2%) were
missed patients. These missed patients were unlikely to
have been much different from included patients, as they
were essentially missing at random. If missed patients are
excluded, the "participation rate" (i.e., the proportion of
patients approached for consent who were included) was
80.8% (177 included/[177 + 38 refusals + three withdraw-
als + one lost]).
Health facility characteristics
Of the 33 facilities, five (15.2%) were hospitals and 28
(84.8%) were health centers. A very large number of
health workers (3564) was estimated in the 57 eligible
facilities (all health workers assigned to the facilities,
including all departments and shifts). A median of five
nurses per facility had AL training. All facilities had at least
one nurse trained to use AL and RDTs.
Among the 33 sampled facilities, 1,103 patients sought
care on the day of the survey visit: 778 (70.5%) initial con-
sultations and 325 (29.5%) follow-up visits. The median
numbers of total and initial consultations/facility/day
were 26 (range: 12-119) and 18 (range: 5-77), respec-
tively.
Nearly all facilities had thermometers and scales; but only
half had AL algorithms (Table 1). All performed malaria
testing. All facilities had AL in stock, and most (72.7%)
had all four AL blister packs. However, two-thirds of facil-
ities had AL stock-outs in the preceding three months, and
most lacked quinine.
Health worker characteristics
Among the 93 interviewed health workers, the median age
was 36 years (range: 21-70), and 51.6% (48/93) were
female. Nearly all (91/93, or 97.8%) were nurses; two
(2.2%) were physicians. Nurses had 2-5 years of pre-serv-
ice medical training. Sixty percent of interviewed health
workers had formal AL training, and two-thirds had infor-
mal AL training (Table 2). Most formal training courses
(89.3%) covered RDT use, training duration was usually
three days (range: 1-15), and most (75.0%) occurred in
2007.
Three-quarters of health workers were supervised in the
preceding six months (median = 1 visit, range: 0-5), but
only one-third reported that supervision included obser-
vation and feedback on a consultation. Half of workers
reported supervision on AL use; and of these, almost half
(20/47, or 42.6%) reported never having received supervi-
sion with observation and feedback on a consultation.
These results reflected the plan to have AL-related supervi-
sion in the first year of AL scale-up focus on pharmaceuti-
cal management.
Health worker caseloads (all consultation types com-
bined) ranged from 1-44 patients/day (median = 13), and
16.3% (15/92 [1 missing]) had high caseloads of ≥ 25
patients/day. A knowledge assessment revealed that no
health worker knew the complete description of which
patients should be tested for malaria--even though work-
ers were told they could consult reference or training
materials during the interview. However, two-thirds (59/
90, or 65.6%) of health workers knew fever was a criterion
for testing.
Responses to case scenarios of hypothetical patients
revealed several patterns. First, in three scenarios describ-
ing adults with fever and a negative test (RDT or micros-
copy), most health workers (72.0-81.7%) seemed to
Dosage for artemether-lumefantrine used in the survey anal- ysis Figure 3
Dosage for artemether-lumefantrine used in the sur-
vey analysis.
• Weight <5 kg: artemether-lumefantrine not recommended
• Weight 5.0–14.9 kg: 1 tablet twice a day for 3 days
• Weight 15.0–24.0 kg: 2 tablets twice a day for 3 days
• Weight 24.1–34.9 kg: 3 tablets twice a day for 3 days
• Weight >35.0 kg: 4 tablets twice a day for 3 days
Notes. Each tablet contained 20 mg of artemether and 120 mg of 
lumefantrine. These dosage definitions were slightly modified 
from those in the National Malaria Control Program (NMCP) 
guidelines because weight categories in the guidelines (<5 kg,  
5–14 kg, 15–24 kg, 24–34 kg, and >35 kg) had gaps and were 
not mutually exclusive. For example, the dosage was not clear 
for patients weighing 14.5 kg (in between 2 weight categories)  
or 24.0 kg (in 2 categories). In practice, difficulty in applying  
the NMCP guidelines was rare (only 2 patients); in these cases, 
dosage was considered correct. Also, regarding routine use of  
the guidelines in the field, the guidelines include a dosage chart 
based on patient age, which health workers can use to overcome 
difficulties related to the weight-specific dosage chart.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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ignore the test and gave an incorrect diagnosis of malaria
or suspected malaria. For nearly all (96-100%) case sce-
nario patients that health workers diagnosed with malaria
or suspected malaria, workers said they would treat with
an anti-malarial. Second, in a scenario of an adult with
fever, convulsions, and a positive blood smear, only two-
thirds of workers (63/93, or 67.7%) correctly diagnosed
severe malaria; but correctly diagnosed cases were usually
(53/63, or 84.1%) treated with an injectable anti-malar-
ial, and nearly all (87/93, or 93.5%) were referred for hos-
pitalization. Third, in three scenarios of patients with
symptoms suggestive of malaria, most workers (76.3-
87.1%) correctly responded that they would test the
patient. Finally, summarizing knowledge across all seven
scenarios, the median percentage of questions correctly
answered per health worker was 56.3% (range: 31.3-
87.5%).
Patient characteristics: demographics, consultation 
attributes, and illnesses
Patient ages ranged from 0-80 years (median = 8), and 72
(45.0%) were under-5s. Ninety-nine (55.9%) patients
were female, and five (2.2%) reported being pregnant.
Half (53.9%) of patients were seen by health workers with
formal AL training, and 75.3% of patients were seen by
workers with any AL training (formal or informal). Only
30.8% of patients sought care on the day of illness onset
or the next day.
The chief complaint of half (49.0%) of patients was fever
or malaria, and 119 (70.5%) had a febrile illness (fever by
history or temperature > 37.5°C). Among these 119
patients, only 69.5% gave a chief complaint of fever or
malaria (85.8% for under-5s and 54.9% for patients ≥ 5
years old). These results show why health workers must
Table 1: Availability of equipment, staff, and medicines needed to manage malaria and other febrile illnesses in outpatient health 
facilities, Huambo Province, Angola
Characteristic Health facilities with the characteristic (N = 33)
No. % (95% CI)
Thermometer 28 84.8 (76.8-92.9)
Functional scale for weighing children 32 97.0 (93.1-100)
Booklet or chart with AL treatment algorithms for children and adults 16 48.5 (37.3-59.6)
Staff trained to perform microscopy 19 57.6 (46.5-68.6)
Functional microscope, according to the laboratory technician 19 57.6 (46.5-68.6)
Staff trained to perform RDTs 29 87.9 (80.6-95.2)
At least 25 valid (not expired) RDTs in stock 31 93.9 (88.6-99.3)
Malaria testing, by microscopy or RDTa 33 100 (89.4-100)
Malaria testing, by both microscopy and RDTsb 13 39.4 (28.5-50.3)
Mosquito bed nets for distribution to patientsc 0 0 (0-10.9)
Medicines in stock on the day of the survey visit
AL blister packs for patients 5-14 kg 26 78.8 (69.7-87.9)
AL blister packs for patients 15-24 kg 33 100 (89.4-100)
AL blister packs for patients 25-34 kg 33 100 (89.4-100)
AL blister packs for patients ≥ 35 kg 30 90.9 (84.5-97.3)
All four AL blister packs 24 72.7 (62.8-82.7)
Amodiaquine tablets 29 87.9 (80.6-95.2)
Quinine tablets 12 36.4 (25.6-47.1)
Quinine or quinidine (injectable) 18 54.4 (43.4-65.7)
Oral antibiotic (amoxicillin, ampicillin, cotrimoxazole, or erythromycin) 31 93.9 (88.6-99.3)
Iron tablets 27 81.8 (73.2-90.4)
Medicines in stock every day for the 3 months before the survey visit
AL blister packs for patients 5-14 kg 7 21.2 (12.1-30.3)
AL blister packs for patients 15-24 kg 12 36.4 (25.6-47.1)
AL blister packs for patients 25-34 kg 12 36.4 (25.6-47.1)
AL blister packs for patients ≥ 35 kg 10 30.3 (20.0-40.6)
All four AL blister packs 4 12.1 (4.8-19.4)
AL = artemether-lumefantrine; CI = confidence interval; RDT = rapid diagnostic test for malaria.
a Malaria testing was considered available if, on the day of the survey visit, the health facility had either: 1) a microscopist and a functional 
microscope, or 2) staff trained to perform RDTs and at least 25 valid (not expired) RDTs.
b On the day of the survey visit, the health facility had both of the following: 1) a microscopist and a functional microscope, and 2) a staff person 
trained to perform RDTs and at least 25 valid (not expired) RDTs.
c N = 32 health facilities, one value missing.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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ask about fever and measure temperatures for all patients;
solely relying on chief complaints could lead to many
missed cases of febrile illness.
As defined in Huambo, 136 (77.8%) patients had sus-
pected malaria (fever or three non-fever symptoms), half
(48.0%) of whom had signs of a non-malaria illness--
most commonly, respiratory infections (Table 3). Of 62
under-5s with suspected malaria, 58 (93.5%
[unweighted]) would have been detected by fever history
or measured temperature > 37.5°C alone. That is, if sus-
pected malaria had been defined as "fever history or tem-
perature > 37.5°C", the inclusion of "three non-fever
symptoms" added little benefit (only four more patients,
an additional 6.9% [4/58, unweighted]). For older
patients, the corresponding benefit was somewhat larger:
an additional 21.3% (13/61, unweighted).
According to the analysis algorithm, one patient (0.8%)
had complicated malaria, 58 (35.0%) had uncomplicated
malaria, and 118 (64.2%) had no malaria (Table 3). Pro-
portions were similar for under-5s and older patients. Of
the 59 malaria cases, 17 had a positive malaria test (based
on testing performed by the observed health facility staff-
-not by surveyors); and the other 42 had suspected
malaria, were not tested, and had no other (non-malaria)
cause of fever identified (see Figure 1, footnote 7).
Patient characteristics: quality of clinical assessment and 
use of diagnostic testing
Clinical assessments were evaluated by estimating the
proportion of patients for whom health workers had
determined if a given sign or symptom was present.
"Determined" meant the worker was exposed to the infor-
mation by any means (e.g., spontaneously offered by the
patient, provided by the patient in response to a question,
or obviously evident). This approach avoids penalizing
health workers who do not ask for symptoms when it is
not necessary. Fever history was determined for 87.6% of
patients. However, temperatures were measured in only
25.9% of consultations, and assessment quality was poor
for all other symptoms needed to identify suspected
malaria. Symptom-specific proportions ranged from 1.8%
(fatigue) to 39.2% (headache). A sub-analysis for patients
without fever showed similarly poor quality (details avail-
able on-line) (see Additional file 1).
The pre-September 2007 policy recommended testing all
patients with suspected malaria with microscopy or RDTs.
Thus, 136 (77.8%) patients needed testing (Table 3).
Only 30.7% of patients needing testing were tested,
79.2% of patients not needing testing were not tested (i.e.,
little over-testing), and overall adherence to the policy
was 41.5%. Results did not vary by age.
Univariate statistical modeling identified several factors
that were positively associated with malaria testing among
patients needing testing: increasing supervision on AL use,
lower caseload (< 25 versus ≥ 25 patients), higher patient
temperature, and facility type (health centers versus hos-
pitals) (details available on-line) (see Additional file 1).
Two factors not associated with testing had p-values low
enough (p < 0.15) to retain in the multivariable model:
any AL training (formal or informal) and health worker
age. The following were not associated with testing and
not retained in the model: formal AL training, days of AL
training, health worker knowledge score and sex, chief
complaint of fever or malaria, and patient age and sex.
Multivariable modeling identified two factors signifi-
cantly associated with testing (Table 4). First, the odds of
testing among patients (needing testing) seen by health
workers with caseloads < 25 patients/day were 18-fold
greater than for those seen by workers with higher
caseloads. Based on unadjusted results, the proportion of
patients tested by health workers with lower and higher
Table 2: Health worker training and supervision in outpatient health facilities, Huambo Province, Angola
Characteristic Health workers with the characteristic (N = 93)
No. % (95% CI)
Health worker received at least one formal training on AL use
(i.e., an organized course in a classroom or clinical setting that lasts at least a half day)
56 60.2 (47.7-72.8)
Health worker received informal training on AL use 
(i.e., a short, e.g., 1 hour, impromptu educational session provided by a supervisor or 
peer)
60 64.5 (53.1-75.9)
Health worker received formal or informal training on AL use 72 77.4 (66.6-88.2)
Health worker received at least 1 supervision visit in past 6 months
(any supervision, even if unrelated to malaria)
68 73.1 (63.9-82.4)
Health worker received at least 1 supervision visit in past 6 months in
which the supervisor observed and provided feedback on a consultation
32 34.4 (25.3-43.5)
Health worker supervised at least once in past 6 months on AL use 47 50.5 (40.4-60.7)
AL = artemether-lumefantrine; CI = confidence interval.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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caseloads were 49.0% and 7.5%, respectively--a large dif-
ference of 41.5 percentage points. Second, the odds of
testing increased by 2.5-fold for each increase in patient
temperature by 1°C. Based on predicted probabilities
from the reduced model, for each 1°C increase in temper-
ature (in the 37-39°C range), the proportion of patients
tested increased by about 13-22 percentage points. The
multivariable model also revealed that the association
between testing and any AL training (formal or informal)
was of borderline statistical significance (odds ratio = 5.4;
p = 0.072). Based on unadjusted results, the proportion of
patients tested by health workers with any AL training and
no AL training were 38.1% and 17.2%, respectively--a
moderate difference of 20.9 percentage points.
Patient characteristics: results of malaria testing and 
quality of diagnosis
Among the 69 non-pregnant patients ≥ 5 years old with
suspected malaria tested by surveyors with microscopy, 2
(3.4%; 95% CI: 0-8.5) were parasitemic with P. falciparum.
Health workers tested 64 patients, 62 of whom had results
available the same day and were included in subsequent
analyses. Of these 62 patients, 50 were tested only with
RDTs, 9 with smears only, and 3 with both an RDT and
smear. Seventeen (27.4%) of these 62 patients tested pos-
itive, and results were similar for under-5s (8/30, or
26.7%) and patients ≥ 5 years old (9/32, or 28.1%).
Among the 27 patients tested by surveyors with micros-
copy (the gold standard for evaluating diagnostics) and by
health workers (with RDT or microscopy), the sensitivity
of health worker testing was 2/2, and the specificity was
19/25 (76.0%, unweighted). Results for health worker
RDTs only were similar (sensitivity = 2/2, specificity= 17/
22, or 77.3%, unweighted).
With the analysis algorithm as the standard, 66.1% of
health workers' malaria-related diagnoses were correct,
20.1% were minor errors, and 13.9% were major (poten-
tially life-threatening) errors (Table 5). With survey micro-
scopy as the standard: a) for the one microscopy-positive
case of uncomplicated malaria, the health worker's diag-
nosis was uncomplicated malaria (correct); b) for the one
microscopy-positive case of complicated malaria, the
worker's diagnosis was uncomplicated malaria (major
error); and c) for the 70 microscopy-negative cases, work-
ers correctly diagnosed no malaria in 34 cases (48.6%,
unweighted) and incorrectly over-diagnosed malaria in
36 cases (51.4%, unweighted).
Table 3: Patient characteristics in outpatient health facilities, Huambo Province, Angola
Characteristic No. and weighted percentage of patients
n/N % (95% CI)
Patient had suspected malariaa
Among all patients 136/177 77.8 (69.5-86.2)
Among patients < 5 years old 62/72 79.5 (65.3-93.7)
Among patients ≥ 5 years old 74/105 76.5 (66.1-86.9)
Patient (all ages) with suspected malaria had symptoms of a non-malaria cause of the febrile illness 
(e.g., a respiratory infection)
63/136 48.0 (36.8-59.3)
Malaria diagnoses according to the analysis algorithm (Figure 1)
Complicated malaria 1/177 0.8 (0-2.4)
Uncomplicated malaria 58/177 35.0 (26.0-44.1)
Not malaria 118/177 64.2 (55.1-73.3)
Patient was tested for malaria with either microscopy or a rapid diagnostic test, whether or not 
indicated by the policy
64/177 28.5 (17.9-39.2)
Appropriateness of malaria testing
Patient with suspected malaria (i.e., test needed) was testedb 58/136 30.7 (17.9-43.6)
Patient without suspected malaria (i.e., no test needed) was not tested 35/41 79.2 (60.5-97.9)
Overall adherence to the testing policy (all ages)c 93/177 41.5 (30.2-52.7)
Overall adherence to the testing policy (age < 5 years old)c 36/72 40.0 (25.0-55.0)
Overall adherence to the testing policy (age ≥ 5 years old)c 57/105 42.7 (27.7-57.6)
CI = confidence interval.
a Defined as either fever (history of fever or axillary temperature > 37.5°C), or at least 3 of the following: headache, joint pain, chills, sweating, 
anaemia (palmor pallor), cough (applies to children only), anorexia, fatigue, vomiting, or diarrhoea.
b Microscopy and malaria rapid diagnostic tests were considered as equally appropriate tests.
c Patients needing testing got tested, and patients not needing testing did not get tested.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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Laboratory assessment
Twenty-two staff from a convenience sample of 20 facili-
ties were assessed as they performed RDTs. All the correct
steps (one drop of blood and six drops of buffer solution)
were followed in only half (11/22) of observations. The
most common error was using too little buffer solution
(two to five drops). The amount of blood was usually cor-
rect. Most staff knew that one should wait 15 minutes or
a little longer, although one-third might have thought
that waiting times were < 15 minutes or were unsure.
Additionally, in some facilities, test results were reported
in batches instead of reporting individual results as they
were ready. This practice caused unnecessarily long wait-
ing times (≥ 1 hour) for some patients (RDT results
should be available in < 30 minutes).
Patient characteristics: quality of treatment and 
counseling
Among all 177 patients, 61.4% of prescribed malaria-
related treatments were correct, 22.3% were minor errors,
and 16.3% were major (potentially life-threatening)
errors (Table 6). The most common errors were prescrib-
ing no anti-malarials for patients with uncomplicated
malaria and prescribing AL for patients without malaria.
Errors such as under-dosing AL and using ineffective anti-
malarials were uncommon.
Among the 59 patients with malaria, the quality of pre-
scribed treatments was lower: only 49.0% were correct,
5.4% were minor errors, and 45.6% were major errors
(Table 6). In an analysis of treatment quality from the
patient's perspective (i.e., patient left the facility with the
anti-malarial in hand and demonstrated knowledge on
administering it at home), only 27.1% of patients
received recommended care, 5.4% received adequate (but
not recommended) care, and 67.5% received inadequate
care.
An analysis of 62 patients prescribed AL (whether or not
it was indicated) revealed that health workers almost
always dosed AL correctly, but the quality of counseling
was mixed (Table 7). Nearly all patients received the cor-
rect dose (95.1%) and complete dosing instructions
(88.2%). However, only 60.9% of patients could repeat
all the dosing instructions. Furthermore, few patients were
given the first dose during the consultation (10.7%) or
advised to take the medicine with food (31.3%).
Graphical pathway analysis
A graphical pathway analysis was performed to link
results of individual steps of the case-management proc-
ess and identify strengths and weaknesses of health
worker practices. For simplicity, percentages are
unweighted. Among the 40 patients without febrile ill-
Table 4: Predictorsa of correct malaria testing among patients with suspected malariab in outpatient health facilities, Huambo 
Province, Angola
Attribute No. of patients tested/no. of patients who 
needed testing (weighted %)
Multivariate
odds ratio
(95% confidence interval)
p-value
Health worker's caseload (all patients) on the day of 
the survey visit
0-24 patients 53/103 (49.0) 18.4 (6.8-49.6) < 0.0001
25-43 patients 3/27 (7.5) reference
Patient's temperature measured by surveyor 
(N = 135; 1 missing value)
39.0-39.9°C 9/11 (80.5%) odds ratio per 1°C  0.0073
38.0-38.9°C 3/9 (29.9%) increase in measured 
37.0-37.9°C 19/37 (30.2%) temperature:
36.0-36.9°C 25/70 (26.2%) 2.5 (1.3-5.0)
35.0-35.9°C 1/8 (6.0%)
Health worker training on case-management policy 
recommending AL and diagnostic testing
Any training (formal or informal training) 48/99 (38.1%) 5.4 (0.9-33.5) 0.072
Not trained 9/32 (17.2%) reference
AL = artemether-lumefantrine.
a This table presents results from the reduced model, which only included variables with multivariable p-values < 0.10. The full model, which 
included all variables with a univariate p-value < 0.15, also included health facility type (hospital versus health center), health worker supervised on 
AL use in the past 6 months, and health worker's age. In the full model, none of these factors had statistically significant associations with malaria 
testing (p-values ranged from 0.12 to 0.99). Both the full and reduced models were based on analyses of 129 patients because of missing values of 
predictors. The r-squared value for the full and reduced models were 94.9% and 94.4%, respectively.
b In this analysis, all the patients needed testing by either microscopy or a rapid diagnostic test.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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ness/suspected malaria (and thus no malaria), we found
that a large majority of patients (35/40, or 87.5%) were
not tested for malaria, nearly all (34/35, or 97.1%) of
these untested patients were not diagnosed with malaria;
and of the 34 patients without a malaria diagnosis, none
were treated with an anti-malarial (Figure 4, steps along
the bottom of the figure). In other words, most patients
were managed correctly at all points in the case-manage-
ment process.
Among the 78 patients with febrile illness/suspected
malaria but no gold standard malaria diagnosis, many
(36/78, or 46.2%) were not tested, even though they
should have been (Figure 5). Among the 41 patients with
a negative test result, over half (24/41, or 58.5%) were
diagnosed with malaria. Nearly all (33/36, or 91.7%)
patients diagnosed with malaria were prescribed an effec-
tive anti-malarial; and of the 42 patients without a malaria
diagnosis, none were treated with anti-malarials.
Among the 59 patients with febrile illness/suspected
malaria and a gold standard malaria diagnosis, most (42/
58, or 72.4%) were not tested, even though they should
have been (Figure 6). Of 26 patients who did not receive
anti-malarials (major error), none had been tested. All 17
patients with a positive malaria test were diagnosed with
malaria. A large majority of patients (31/35, or 88.6%)
diagnosed with malaria were prescribed effective anti-
malarials; and of the 24 patients without a malaria diag-
nosis, none were treated with anti-malarials.
In summary, many patients who should have been tested
were not, which led to many incorrect diagnoses. Health
workers did not trust their negative test results: over half
of test-negative patients were diagnosed with malaria (26/
45, or 57.8%) and treated with anti-malarials (27/45, or
60.0%). Results were similar for microscopy and RDTs,
but distrust was greater when the patient was ≥ 5 years old.
Malaria was diagnosed in 73.9% (17/23) of test-negative
patients ≥ 5 years old (versus 40.9% [9/22] for under-5s),
and anti-malarials were prescribed for 73.9% (17/23) of
test-negative patients ≥ 5 years old (versus 45.5% [10/22]
for under-5s). Health workers did trust positive test
results, as all test-positive patients were diagnosed with
malaria. Prescribed treatments closely matched health
worker diagnoses: among 73 patients whom workers diag-
Table 5: Quality of malaria diagnosis in outpatient health facilities, Huambo Province, Angola
Characteristic and patient sub-group No. and weighted percentage of patients
n % (95% CI)
Health worker's malaria-related diagnosis for the 1 patient with a gold standard diagnosisa of complicated 
malaria
Uncomplicated malaria (major error) 1 100 (NC)
Health workers' malaria-related diagnoses for the 58 patients with a gold standard diagnosisa of uncompli-
cated malaria
Complicated malaria (minor error) 2 2.6 (0-6.4)
Uncomplicated malaria (correct) 32 60.1 (44.5-75.7)
No malariab (major error) 24 37.4 (21.6-53.1)
Health workers' malaria-related diagnoses for the 118 patients with a gold standard diagnosisa of no 
malaria
Uncomplicated malaria (minor error) 40 29.9 (17.6-42.2)
No malaria (correct) 78 70.1 (57.8-82.4)
Overall quality of health workers' malaria-related diagnoses among all 177 patients
Correct (health worker diagnoses of malaria and no malaria matched gold standard diagnoses) 110 66.1 (58.3-73.8)
Minor error 
(health worker incorrectly "over-diagnosed" uncomplicated malaria as complicated malaria, or 
over-diagnosed no malaria as uncomplicated malaria)
42 20.1 (11.4-28.7)
Major error 
(health worker incorrectly "under-diagnosed" complicated malaria as uncomplicated malaria, 
or under-diagnosed uncomplicated malaria as no malaria)
25 13.9 (8.0-19.7)
CI = confidence interval; NC = not calculated.
a The "gold standard" malaria diagnosis (against which health worker diagnoses were compared) was defined by applying the analysis algorithm 
(Figure 1) to patient clinical signs and symptoms (assessed by surveyors, but information that should have been available to observed health 
workers) and laboratory data available to observed health workers (i.e., not the survey team's laboratory results).
b Health workers' diagnoses of the 24 patients were gastrointestinal illnesses (n = 10; e.g., gastritis, intestinal parasites, and dysentery), respiratory 
illnesses (n = 5; e.g., bronchitis), skin problems (n = 2; e.g., scabies and skin boils), and other (n = 7; e.g., dental caries, trauma, chicken pox, and 
malnutrition).Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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nosed with uncomplicated malaria, a large majority
(83.6%) received AL (usually correctly dosed); and among
102 patients without a diagnosis of malaria, nearly all
(97.3%) received no anti-malarial treatment.
Design effects and intraclass correlation coefficients
Design effects and intraclass correlation coefficients ( )
were examined for 24 key patient-level indicators of case-
management quality related to patient assessment, diag-
nosis, treatment, and counseling. Weighted design effects
ranged from about 1.0 (no correlation) to 3.4 (moderate
correlation); the median was 1.7. Weighted values of 
ranged from just under zero to about 1.0; the median was
0.3. Design effects for the two indicators of correct malaria
treatment were close to one (i.e., 1.1 and 1.6), which
reflects relatively little correlation.
As heterogeneous analysis weights tend to increase design
effects and decrease precision [19], an unweighted analy-
sis was performed to quantify the effect of heterogeneous
weights (final weights ranged from 1.7-40.6). As expected,
unweighted design effects and   were usually lower than
values from the weighted analysis. An examination of the
ratio of weighted design effects to unweighted design
effects revealed a median ratio of 1.48. In other words,
heterogeneous weights typically increased design effects
by 48%, which widened CIs by 22% (i.e., square-root
[1.48] = 1.22) (details available on-line) (see Additional
file 1).
Discussion
This survey evaluated about 14 months of activities to
scale-up Angola's ACT policy in a province with weak
infrastructure that was the focus of a well-funded malaria
Table 6: Quality of malariaa treatment in outpatient health facilities, Huambo Province, Angola
Characteristic and patient sub-group No. and weighted percentage of patients
n % (95% CI)
Quality of malaria treatment among all 177 patientsb
Correct (recommended treatment) 105 61.4 (52.0-70.7)
Minor error 42 22.3 (12.3-32.3)
Major error 30 16.3 (10.2-22.4)
Quality of malaria treatment among the 59 patients with malariab
Correct (recommended treatment) 27 49.0 (33.5-64.5)
Minor errorc 2 5.4 (0-13.2)
Major errord 30 45.6 (28.2-63.1)
Quality of malaria treatment for the 59 malaria cases 
(quality in terms of antimalarials obtained by patients and patient recall of treatment instructions)
Patient left the health facility with the recommended anti-malarial and knowledge of how to 
administer the drug at home
17 27.1 (14.8-39.4)
Patient left the health facility with an adequate (but not recommended) anti-malarial and 
knowledge of how to administer the drug at home
2 5.4 (0-13.2)
Patient left the health facility without at least one of the following: an effective anti-malarial or 
adequate knowledge of how to administer the drug at home
40 67.5 (53.6-81.5)
Quality of malaria treatment among the 118 patients without malariab
Correct (recommended treatment) 78 68.3 (54.6-82.0)
Minor error 40 31.7 (18.0-45.4)
AL = artemether-lumefantrine; CI = confidence interval.
a The "gold standard" malaria diagnosis (against which health worker treatments were compared) was defined by applying the analysis algorithm 
(Figure 1) to patient clinical signs and symptoms (assessed by surveyors, but information that should have been available to observed health 
workers) and laboratory data available to observed health workers (i.e., not the survey team's laboratory results).
b Quality in terms of anti-malarials prescribed by health workers. No error means that patients received recommended treatment in exact 
accordance with guidelines (malaria cases treated with the recommended anti-malarial with the recommended dosage, and non-malaria cases 
received no anti-malarial treatment). Minor error means that malaria cases received non-recommended, but still life-saving, anti-malarial treatment 
(either an overdose of a recommended anti-malarial, or an adequate dose of a non-recommended anti-malarial); and non-malaria cases received 
unnecessary anti-malarial treatment that was unlikely to cause serious harm. Major error means that malaria cases did not receive life-saving 
treatment (no anti-malarial, an ineffective anti-malarial, or an under-dosed anti-malarial).
c The 2 minor errors were: 1 case of uncomplicated malaria treated with correctly dosed quinine, and 1 case of uncomplicated malaria in a child < 
5 kg treated with AL (with a dosage appropriate for a child 5-14 kg).
d The 30 major errors were: 26 cases of uncomplicated malaria not treated with anti-malarials, 2 cases of uncomplicated malaria treated with 
ineffective anti-malarials (1 treated with amodiaquine, 1 treated with sulfadoxine-pyrimethamine), 1 case of uncomplicated malaria treated with 
underdosed AL, and 1 case of complicated malaria treated with underdosed AL.Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
Page 14 of 20
(page number not for citation purposes)
control initiative. As the survey occurred in the middle of
a multi-year implementation plan and as training and
supervision have continued since the survey, the current
situation is probably better than what is reflected in this
report. However, the programmatic strengths and weak-
nesses we identified were notable, and the results reveal
problems that might exist today. Moreover, as the setting
is typical of many parts of the developing world, the
broader lessons might be relevant to other low-income
countries.
The first main finding was related to the fact that when a
policy is ambiguous, overly complex, communicated
imprecisely, or changed frequently, confusion can ripple
throughout the health system. In Angola, in 2007, parts of
the NMCP policy lacked clarity. In Huambo, local staff
responded by adding details in training materials to fill
gaps. However, despite these good intentions, the result
was that nearly everyone involved in scale-up activities
had a different interpretation of the guidelines. Addition-
ally, the complex definition of suspected malaria likely
contributed to the finding that no health worker knew the
full definition. These observations underscore the impor-
tance of developing policies and training materials that
are clearly written and as simple as possible. Donors and
other development partners should insist that these fun-
damental programmatic building blocks be in place
before large-scale implementation activities are under-
taken. Furthermore, the statement that patients might
have malaria even with a negative test, which appears in
policy statements from Angola and other countries [5,20],
should be replaced with more specific guidance. At the
international level, experts can assist by helping to answer
the question: precisely who should be treated when a test
is negative? Without specific guidance, health workers are
justified in ignoring negative test results; and if instances
exist when test results can be ignored, some workers might
conclude that testing has limited value and can be
skipped.
The second finding was that many case-management ele-
ments were in place, although some additional strength-
ening was needed. All facilities had AL in-stock, the ability
to perform malaria testing, and AL-trained health workers.
Although scale-up was still ongoing, aspects of health
facility preparedness requiring improvement during the
Table 7: Use of AL: frequency of prescription, and appropriateness of dosing and counseling (whether or not AL was indicated, 
according to guidelines) in outpatient health facilities, Huambo Province, Angola
Characteristic and patient sub-group No. and weighted percentage of patients
n % (95% CI)
AL prescribed (whether or not indicated, according to guidelines) among all 177 patients 62a 35.5 (24.9-46.2)
Quality of dosing for the 62 patients who received AL
Correctly dosed 59 95.1 (89.2-100)
Underdosed 2 3.9 (51.4-88.4)
Overdosed 0 0 (NC)
AL not recommended (weight < 5 kg) 1 1.0 (0-3.1)
First AL dose given during consultation (for the 62 patients who received AL) 9 10.7 (1.2-20.3)
Quality of counseling for the 62 patients who received AL
HW gave complete dosing instructions (definition of a dose, no. of doses/day, and treatment 
duration)b
55 88.2 (78.3-98.2)
HW advised to take the medicine with food 17 31.3 (12.3-50.2)
Patient could repeat all dosing instructions given by the HW (even if HW's dosage was incorrect)c 43 60.9 (44.2-77.6)
HW advised to take the medicine with milk or fat-containing food 4 4.9 (0-10.8)
HW advised to return for a follow-up visit 8 14.4 (0.4-28.3)
HW advised to sleep under a bed net to prevent malaria 0 0 (NC)
HW advised to return to the health facility if the patient becomes seriously ill 5 5.8 (0-11.8)
HW advised to complete all the treatment (take all medicines) 41 69.9 (51.4-88.4)
AL = artemether-lumefantrine; CI = confidence interval; HW = health worker; NC = not calculated.
a Of these 62 patients, 59 actually had AL in hand; for the other 3 patients, AL had been prescribed but the medicines were not given.
b Dosing instructions were considered complete even if the dosage was incorrect, although in nearly all cases (53 of the 55 patients) the dosage was 
correct.
c Patient had to correctly repeat the definition of a dose, the number of doses per day, and the treatment duration. The response "ate que termine" 
(until all the medicines are done) was considered a correct response for treatment duration. The denominator of this statistic was 60 (2 missing 
values).Malaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
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survey were: oral and injectable quinine were frequently
not in-stock, few facilities had all AL blister packs contin-
uously in the previous three months, one-quarter of
patients were seen by health workers without AL training,
and supervision on AL use was uncommon and often did
not involve observation and feedback. Some of these defi-
ciencies have been observed elsewhere [9]. Additionally,
the health worker knowledge assessment revealed two
major gaps: no one knew the full definition of whom to
test (although most could identify which patients needed
testing in case scenarios), and most did not trust negative
test results. These findings illustrate the importance of
basic program management, in terms of stocking essential
medicines, scheduling trained health workers to perform
consultations, and providing clinical supervision as train-
ing occurs. Although it might not seem directly linked to
lowering malaria mortality, strengthening managerial
capacity should be a priority of today's well-funded dis-
ease control initiatives.
The third main finding was related to case-management
quality. As many indicators are needed for a comprehen-
sive description, we constructed a causal diagram to dis-
play the key practices and show the causal chain of
observed problems (Figure 7). Clearly, this diagram is
simplistic, as it omits many fundamental environmental
factors of potential importance, such as low salaries, poor
motivation, weak infrastructure, and perceived patient
expectations. As illustrated at the top of Figure 7, the case-
management process begins with patient assessment.
Except for fever history, assessments were often incom-
plete. Other studies have found similar deficiencies
[20,21].
Regarding malaria testing, the main problem was substan-
tial under-use. We explored testing practices in-depth
because testing and trusting the result was the key to mak-
ing a correct diagnosis and correct diagnosis was the key
to prescribing appropriate treatments. Interestingly, the
factors significantly associated with testing were caseload
and patient temperature (root causes on the left of Figure
7). Similar analyses from Tanzania [22] and Zambia [21]
in the pre-ACT era found a variety of factors positively
associated with testing: patient age ≥ 15 years, fever, fever
history, and longer travel time to clinic. Testing was less
likely if patients had a skin problem or single-etiology ill-
ness (e.g., respiratory infection alone). These results illus-
trate the importance of non-intervention environmental
factors [23] and could be used to guide future quality
improvement activities (e.g., changing schedules to
reduce high caseloads, and teaching health workers to test
all patients with fever history, not just those with elevated
temperatures). AL training had a borderline association
with testing; but even ignoring statistical significance, the
Graphical pathway analysis of the case-management process for 40 patients without suspected malaria Figure 4
Graphical pathway analysis of the case-management process for 40 patients without suspected malaria. AL = 
artemether-lumefantrine; HW = health worker.
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absolute proportion of patients tested by AL-trained work-
ers was low (38.1%). Supervision on AL was not associ-
ated with testing, perhaps because it focused on
pharmaceutical management rather than clinical practice.
It was notable that health worker knowledge was not asso-
ciated with correct testing, which might explain the mod-
est effect of training. The lack of association between
health worker knowledge and practice has been observed
in other settings [24-26], and this phenomenon should
make program managers consider other quality improve-
ment strategies besides training--such as incentives, job
aids, and quality management principles to name a few
[23].
The patterns of diagnosis and treatment quality were sim-
ilar to those of testing. Only half to two-thirds of patients
were correctly diagnosed and treated. The two most com-
mon diagnostic errors were missing malaria cases and
over-diagnosing malaria among patients without it. Over-
diagnosis can be partly explained by workers' apparent
distrust of negative test results, which echoes results of the
knowledge assessment. Erroneous diagnoses translated
into inappropriate treatments because, in general, workers
correctly treated the diagnoses they made. Additionally,
health workers rarely administered the first dose of AL
during the consultation (perhaps because no food was
available), and many aspects of counseling needed
improvement--problems found in other settings [4,9]. An
analysis from the patient's perspective, which was perhaps
the most relevant quality indicator (i.e., patients needing
treatment left the facility with the correct medicine and
knowledge on administering it at home), found that only
about one-third of patients received adequate (i.e., life-
saving) care.
These results point to what might be the most important
lesson of our evaluation and other similar studies [3-9]:
commonly-used scale-up strategies such as providing
commodities, cascade training, job aids, and a little super-
vision of uncertain quality, seem to have only a moderate
effect. Moreover, implementation of these strategies is
time-consuming. For malaria control initiatives to achieve
better results faster, new approaches are needed.
There were several important positive findings related to
treatment. For example, it was reassuring that nearly all
patients that health workers diagnosed with malaria were
prescribed AL at the correct dose and provided with accu-
rate dosing instructions. Also, there was little use of inef-
fective and non-recommended anti-malarials--a problem
observed elsewhere [3,6,27].
Methodological lessons
This survey provided several methodological lessons.
First, it was challenging to develop the definition of the
gold standard against which case-management quality
Graphical pathway analysis of the case-management process for 78 patients with suspected malaria but no gold standard  malaria diagnosis Figure 5
Graphical pathway analysis of the case-management process for 78 patients with suspected malaria but no 
gold standard malaria diagnosis. AL = artemether-lumefantrine; HW = health worker.
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should be evaluated. Should the definition be based on a
draft policy document; verbal explanations of NMCP offi-
cials; or what was taught in training courses? Ultimately,
two parallel analyses were performed to take the perspec-
tive of what had been taught to health workers (presented
in this report), and then, as the policy was evolving, what
NMCP officials wanted the policy to be (details available
on-line) (see Additional file 1).
The second lesson concerned the "follow the patient"
sampling method. This method allows surveyors to
observe all parts of the patient's clinic visit and might
reduce loss after enrollment. However, clearly, many
patients were missed because of an insufficient number of
surveyors and because health workers did not always see
patients in the order they arrived at the facility (e.g., if
patient 1 was selected for inclusion but not immediately
seen by a health worker, a surveyor had to wait for patient
1's consultation, during which time other sampled
patients might be seen by health workers). Also, the
method led to widely varying analysis weights, which
reduced precision. Another approach, which is probably
better, is to have surveyors at fixed stations (e.g., observers
spend the entire visit observing consultations). The disad-
vantage of the fixed-station method is that a small survey
team might miss consultations in facilities with several
consultation rooms. The solution is to either randomly
select consultation rooms (and record selection probabil-
ities, so results can be weighted) or determine in advance
the number of consultation rooms in each sampled facil-
ity and create a small pool of extra surveyors to work at the
larger facilities.
Finally, this survey demonstrated the positive bias that
can occur when quality is evaluated only by measuring
how well prescriptions match health worker diagnoses.
With this approach, quality seemed excellent. Most
(83.6%) patients whom workers diagnosed with malaria
received AL, and nearly all (97.3%) patients whom work-
ers did not diagnose with malaria were not prescribed
anti-malarials. In contrast, when quality was assessed with
a gold standard based on expert re-examination, results
were much lower.
Graphical pathway analysis of the case-management process for 59 patients with a gold standard malaria diagnosis Figure 6
Graphical pathway analysis of the case-management process for 59 patients with a gold standard malaria diag-
nosis. AL = artemether-lumefantrine; HW = health worker. a None of these 26 patients had been tested for malaria, although 
all were seen at health facilities in which testing was available.
HW 
diagnosed 
severe 
malaria (n=2)
Patients 
tested, 
result 
positive 
(n=16)
AL prescribed 
(n=29), most 
correctly dosed 
(27/29, or 93%)
Quinine 
prescribed, 
correctly dosed 
(n=1)
Ineffective 
antimalarial 
prescribed   
(n=2)
No antimalarial 
prescribeda
(n=26)
Patients with 
gold standard 
diagnosis of 
uncomplicated 
malaria (n=58)
16 
(28%)
42 
(72%)
2 
(13%)
14 
(88%)
2 
(100%)
HW   
diagnosed 
uncomplicated 
malaria 
(n=32)
27 (84%)
1 (3%)
2 (6%)
2 (6%)
24 
(100%)
HW did not 
diagnose 
malaria 
(n=24)
Patients    
not 
tested 
(n=42)
18 
(43%)
24 
(57%)
Patient with gold 
standard diagnosis of 
severe malaria (n=1)
HW diagnosed 
uncomplicated malaria
AL prescribed 
(n=1)
Patient tested, 
result positiveMalaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
Page 18 of 20
(page number not for citation purposes)
Limitations
The survey has several important limitations. First, it only
included facilities in which ACT implementation activities
had occurred. Therefore, results cannot be generalized to
facilities where many patients might seek care--especially
government-run health posts and private-sector facilities.
Second, the response rate was low because surveyors
missed eligible patients, although it seems unlikely that
missing these patients introduced a large bias. Third,
directly observing consultations could have caused health
workers to be more careful than usual [28,29], thus over-
estimating case-management quality somewhat. Fourth,
some patient groups with suspected malaria were not
tested. This issue, along with the survey period occurring
before the peak malaria season (the rains began late), led
to a patient sample size that was too small to evaluate the
performance characteristics of microscopy and RDTs ade-
quately. Moreover, by missing the peak malaria season,
the parasite prevalence might not be a reliable estimate for
characterizing the level of malaria transmission intensity
in the province. Lastly, there was some ambiguity in the
gold standard diagnosis and treatment for cases in which
health workers did not test patients who should have been
tested or vice-versa, although the survey's general conclu-
sions were unlikely to have been affected.
Conclusion
Huambo Province is a challenging place to scale-up a new
case-management policy that recommends a new drug,
emphasizes diagnostic testing, and introduces a new test.
As of late-2007, the scale-up process was well underway,
and the survey had important positive findings. However,
key gaps were found. In particular, the ambiguous policy,
under-use of malaria testing, and distrust of negative test
results led to many incorrect malaria diagnoses and treat-
ments. In 2009, Angola published a policy that clarified
many issues. As problems identified in the survey are not
unique to Angola, better strategies for improving health
worker adherence to guidelines are urgently needed. Sur-
veys that assess case-management quality with observa-
tions of consultations can provide crucial information for
developing local recommendations and guiding scale-up
elsewhere.
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Causal diagram of the case-management process in outpatient health facilities, Huambo Province, Angola Figure 7
Causal diagram of the case-management process in outpatient health facilities, Huambo Province, Angola.
Some ambiguities 
in the policy
Complex 
definition of 
suspected malaria
Survey done 
before scale-up 
activities were 
completed
Supervision often did 
not include observation 
of consultations and 
feedback to clinicians
Some clinics had high caseloads
Health workers often did not trust negative test results
In general, health workers correctly treated      
the malaria-related diagnoses they made
Not all planned training 
done before the survey
Supervision on ACTs
was just beginning by   
the time of the survey
Health workers 
did not know 
the definition of 
suspected 
malaria; patient 
assessments 
were often 
incomplete
M
o
s
t
 
p
a
t
i
e
n
t
s
 
w
h
o
 
s
h
o
u
l
d
 
h
a
v
e
 
b
e
e
n
 
t
e
s
t
e
d
 
w
e
r
e
 
n
o
t
 
t
e
s
t
e
d
M
a
n
y
 
i
n
c
o
r
r
e
c
t
 
m
a
l
a
r
i
a
-
r
e
l
a
t
e
d
 
d
i
a
g
n
o
s
e
s
M
a
n
y
 
i
n
c
o
r
r
e
c
t
 
m
a
l
a
r
i
a
-
r
e
l
a
t
e
d
 
t
r
e
a
t
m
e
n
t
s
Assessment        Testing      Diagnosis      Treatment    Root causes 
Some patients were afebrile during the consultationMalaria Journal 2009, 8:275 http://www.malariajournal.com/content/8/1/275
Page 19 of 20
(page number not for citation purposes)
interval; NMCP: National Malaria Control Programme;
RDT: rapid diagnostic test; under-5: under 5 years old; and
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